183814-30-4
183814-30-4
Chemical Structure
Formoterol hemifumarate hydrate
- CAS No.: 183814-30-4
- Formula:C19H24N2O4.1/2C4H4O4.H2O
- Molecular Weight:840.91
SMILES: OC(/C=C/C(O)=O)=O.COC(C=C1)=CC=C1C[C@H](C)NC[C@H](C2=CC(NC=O)=C(C=C2)O)O.O.[1/2]
Biological Activity: Formoterol hemifumarate hydrate is a selective, long-acting beta 2-adrenoceptor agonist. Formoterol is a bronchodilator used for the research of the asthma and chronic obstructive pulmonary disease (COPD). Formoterol hemifumarate hydrate induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Formoterol hemifumarate hydrate | 99.91% | Formoterol hemifumarate hydrate is a selective, long-acting beta 2-adrenoceptor agonist. Formoterol is a bronchodilator used for the research of the asthma and chronic obstructive pulmonary disease (COPD). Formoterol hemifumarate hydrate induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Formoterol hemifumarate hydrate (Standard) | ≥98% | Formoterol (hemifumarate hydrate) (Standard) is the analytical standard of Formoterol (hemifumarate hydrate). This product is intended for research and analytical applications. Formoterol hemifumarate hydrate is a selective, long-acting beta 2-adrenoceptor agonist. Formoterol is a bronchodilator used for the research of the asthma and chronic obstructive pulmonary disease (COPD). Formoterol hemifumarate hydrate induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Bartow RA, et al. An update of its pharmacological properties and therapeutic efficacy in the management of asthma [published correction appears in Drugs 1998 Apr;55(4):517]. Drugs. 1998;55(2):303-322. [Content Brief]
- [2]. Tashkin DP. Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:3105-3122. Published 2020 Nov 27. [Content Brief]
- [3]. Vekaria HJ, et al. Formoterol, a β2-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury. Neurobiol Dis. 2020;140:104866. [Content Brief]
